Transdermal Drug Delivery System Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 1345 | Published Date: Dec 2024 | No. of Page: 115 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM INDUSTRY
    2.1 Summary about Transdermal Drug Delivery System Industry
    2.2 Transdermal Drug Delivery System Market Trends
        2.2.1 Transdermal Drug Delivery System Production & Consumption Trends
        2.2.2 Transdermal Drug Delivery System Demand Structure Trends
    2.3 Transdermal Drug Delivery System Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Fentanyl
        4.2.2 Nitroglycerin
        4.2.3 Estradiol
        4.2.4 Nicotine
        4.2.5 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 OTC
        4.3.2 Rx
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Fentanyl
        5.2.2 Nitroglycerin
        5.2.3 Estradiol
        5.2.4 Nicotine
        5.2.5 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 OTC
        5.3.2 Rx
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Fentanyl
        6.2.2 Nitroglycerin
        6.2.3 Estradiol
        6.2.4 Nicotine
        6.2.5 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 OTC
        6.3.2 Rx
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Fentanyl
        7.2.2 Nitroglycerin
        7.2.3 Estradiol
        7.2.4 Nicotine
        7.2.5 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 OTC
        7.3.2 Rx
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Fentanyl
        8.2.2 Nitroglycerin
        8.2.3 Estradiol
        8.2.4 Nicotine
        8.2.5 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 OTC
        8.3.2 Rx
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Fentanyl
        9.2.2 Nitroglycerin
        9.2.3 Estradiol
        9.2.4 Nicotine
        9.2.5 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 OTC
        9.3.2 Rx
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Hisamitsu
        10.1.2 Mylan
        10.1.3 GSK
        10.1.4 Novartis
        10.1.5 Teve (Actavis)
        10.1.6 Johnson & Johnson
        10.1.7 Lohmann
        10.1.8 Teikoku Seiyaku
        10.1.9 Bayer
        10.1.10 Lingrui
        10.1.11 Sanofi
        10.1.12 Qizheng
        10.1.13 Endo
        10.1.14 Huarun 999
        10.1.15 Haw Par
        10.1.16 Nichiban
        10.1.17 Mentholatum Company
        10.1.18 Laboratoires Genevrier
    10.2  Transdermal Drug Delivery System Sales Date of Major Players (2017-2020e)
        10.2.1 Hisamitsu
        10.2.2 Mylan
        10.2.3 GSK
        10.2.4 Novartis
        10.2.5 Teve (Actavis)
        10.2.6 Johnson & Johnson
        10.2.7 Lohmann
        10.2.8 Teikoku Seiyaku
        10.2.9 Bayer
        10.2.10 Lingrui
        10.2.11 Sanofi
        10.2.12 Qizheng
        10.2.13 Endo
        10.2.14 Huarun 999
        10.2.15 Haw Par
        10.2.16 Nichiban
        10.2.17 Mentholatum Company
        10.2.18 Laboratoires Genevrier
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
1.Table Transdermal Drug Delivery System Product Type Overview
2.Table Transdermal Drug Delivery System Product Type Market Share List
3.Table Transdermal Drug Delivery System Product Type of Major Players
4.Table Brief Introduction of Hisamitsu
5.Table Brief Introduction of Mylan
6.Table Brief Introduction of GSK
7.Table Brief Introduction of Novartis
8.Table Brief Introduction of Teve (Actavis)
9.Table Brief Introduction of Johnson & Johnson
10.Table Brief Introduction of Lohmann
11.Table Brief Introduction of Teikoku Seiyaku
12.Table Brief Introduction of Bayer
13.Table Brief Introduction of Lingrui
14.Table Brief Introduction of Sanofi
15.Table Brief Introduction of Qizheng
16.Table Brief Introduction of Endo
17.Table Brief Introduction of Huarun 999
18.Table Brief Introduction of Haw Par
19.Table Brief Introduction of Nichiban
20.Table Brief Introduction of Mentholatum Company
21.Table Brief Introduction of Laboratoires Genevrier
22.Table Products & Services of Hisamitsu
23.Table Products & Services of Mylan
24.Table Products & Services of GSK
25.Table Products & Services of Novartis
26.Table Products & Services of Teve (Actavis)
27.Table Products & Services of Johnson & Johnson
28.Table Products & Services of Lohmann
29.Table Products & Services of Teikoku Seiyaku
30.Table Products & Services of Bayer
31.Table Products & Services of Lingrui
32.Table Products & Services of Sanofi
33.Table Products & Services of Qizheng
34.Table Products & Services of Endo
35.Table Products & Services of Huarun 999
36.Table Products & Services of Haw Par
37.Table Products & Services of Nichiban
38.Table Products & Services of Mentholatum Company
39.Table Products & Services of Laboratoires Genevrier
40.Table Market Distribution of Major Players
41.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
42.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
43.Table Global Transdermal Drug Delivery System Market Forecast (Million USD) by Region 2021f-2026f
44.Table Global Transdermal Drug Delivery System Market Forecast (Million USD) Share by Region 2021f-2026f
45.Table Global Transdermal Drug Delivery System Market Forecast (Million USD) by Demand 2021f-2026f
46.Table Global Transdermal Drug Delivery System Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Transdermal Drug Delivery System Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Transdermal Drug Delivery System Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Transdermal Drug Delivery System Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Transdermal Drug Delivery System Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Transdermal Drug Delivery System Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Transdermal Drug Delivery System Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Transdermal Drug Delivery System Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Fentanyl Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Nitroglycerin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Estradiol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Nicotine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Fentanyl Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Nitroglycerin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Estradiol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Nicotine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Fentanyl Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Nitroglycerin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Estradiol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Nicotine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Fentanyl Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Nitroglycerin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Estradiol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Nicotine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Fentanyl Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Nitroglycerin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Estradiol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Nicotine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Rx Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Fentanyl Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Nitroglycerin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Estradiol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Nicotine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
75.Figure OTC Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
76.Figure Rx Segmentat
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Transdermal Drug Delivery System Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Transdermal Drug Delivery System Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Transdermal Drug Delivery System Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports